Top Markets
#1 MowCat MowCat +49.46%
#2 Velvet Velvet +22.61%
#3 Fake World Assets Fake World Assets +18.71%
#4 Block Street Block Street +18.17%
#5 Perle Perle +17.51%
#6 Quack AI Quack AI +15.64%
#7 Bermuda Shorts Bermuda Shorts +14.89%
#8 Derive Derive +14.43%
#9 DUSK Network DUSK Network +13.03%
#10 Epic Chain Epic Chain +12.74%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Braster S.A. Braster S.A.

Braster S.A.

BRA
Rank in Stocks #34866
Braster S.A. globally manufactures and distributes innovative diagnostic... Braster S.A. globally manufactures and distributes innovative diagnostic devices for at-home breast screening. Its product line includes the Braster System, designed for individual at-home breast examinations, and the Braster Pro, tailored for clinical application by healthcare professionals. Initially operating as BRASTER spólka z ograniczona odpowiedzialnoscia, the firm formally changed its designation to Braster S.A. in December 2012. Established in 2008, Braster S.A. is headquartered in Ozarów Mazowiecki, Poland.
Share Price
$0.16328231
Last synced: 2024-07-12
Market Cap
$4.80M
Change (1 day)
17.36%
Change (1 year)
0.00%
Country
PL
Trade Braster S.A. (BRA)

Category

Healthcare
Earnings for Braster S.A. (BRA)
Earnings in 2026 TTM: 0
According to Braster S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Braster S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US